Log in
Enquire now
‌

US Patent 11970539 Antibodies that bind to IL1RAP and uses thereof

Patent 11970539 was granted and assigned to Ichnos Sciences on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Ichnos Sciences
Ichnos Sciences
0
Date Filed
September 14, 2021
0
Date of Patent
April 30, 2024
0
Patent Applicant
Ichnos Sciences
Ichnos Sciences
0
Patent Application Number
17474837
0
Patent Citations
‌
US Patent 7521541 Cysteine engineered antibodies and conjugates
0
‌
US Patent 7527791 Humanized anti-TGF-beta antibodies
0
‌
US Patent 8664475 Plants with increased yield
0
‌
US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7041870 Transgenic transchromosomal rodents for making human antibodies
0
‌
US Patent 7087409 Humanization of murine antibody
0
‌
US Patent 7125978 Promoter for regulating expression of foreign genes
0
‌
US Patent 7189826 Monoclonal human natural antibodies
0
‌
US Patent 7332581 Polypeptide variants with altered effector function
0
Patent Inventor Names
Valentina Labanca
0
Amelie Croset
0
Marie-Agnes Doucey
0
Lamine Mbow
0
Thierry Monney
0
Julie Macoin
0
Jeremy Loyau
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11970539
0
Patent Primary Examiner
‌
Vanessa L. Ford
0
CPC Code
‌
A61P 29/00
0
‌
C07K 2317/76
0
‌
C07K 2317/92
0
‌
C07K 2317/565
0
‌
C07K 2317/33
0
‌
C07K 2317/31
0
‌
C07K 16/2866
0

Find more entities like US Patent 11970539 Antibodies that bind to IL1RAP and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.